CN Patent
CN102532133A — 适用作詹纳斯激酶抑制剂的吖吲哚类
Assigned to Vertex Pharmaceuticals Inc · Expires 2012-07-04 · 14y expired
What this patent protects
本发明涉及适用作詹纳斯激酶抑制剂的吖吲哚类。本发明还提供包含所述化合物的药学上可接受的组合物和将该组合物用于治疗不同疾病、状况和障碍中的方法。
USPTO Abstract
本发明涉及适用作詹纳斯激酶抑制剂的吖吲哚类。本发明还提供包含所述化合物的药学上可接受的组合物和将该组合物用于治疗不同疾病、状况和障碍中的方法。
Drugs covered by this patent
- Zelboraf (vemurafenib) · Hoffmann La Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.